Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupDermatologic OncologyradiotherapyDiseaseMerkel Cell CarcinomaSubgroupICD10C44.9MeSHCarcinoma, Merkel CellSequenceCRBP2/Radiation followed by CRBP 4.5/ETOP80, MCC, part A (PID109) -|- CRBP2/Radiation followed by CRBP 4.5/ETOP80, MCC, part B (PID1111)ChemotherapyChemo-substanceCarboplatinEtoposideChemo-substanceCarboplatinEtoposideChemo-substanceCarboplatinEtoposideChemo-substanceCarboplatinEtoposideNo. Substances12 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronNo. Substances34Protocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentionpalliativeRisksAnemia Hb below 8g/dlEmetogenicity (MASCC/ESMO)Febrile NeutropeniaLeukopeniaNeutropeniaThrombocytopenia below 50 000/µl only studiesPublicationAuthorPoulsen MDiseaseMerkelzellkarzinom, ECOG 0-2OriginDivision of Cancer Services, Princess Alexandra Hospital,University of QueenslandDivision of Cancer Services, Princess Alexandra Hospital, University of QueenslandProtocols in Revision 2 protocols foundProtocols under revision.Carboplatin 2 / Radiation followed by Carboplatin 4.5 / Etoposide 80, Merkel Cell Carcinoma Part B (PID1111 V1.0)Carboplatin 2 / Radiation followed by Carboplatin 4.5, Etoposide 80, Merkel Cell Carcinoma Part A (PID109 V1.0)
